$LMAT
LEMAITRE VASCULAR INC Stock $lmat

$lmat Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000143774923022476 Filed on August 08, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$47.41M	$50.12M
YoY Change	21.48%	19.02%
Cost Of Revenue	$16.60M	$18.03M
YoY Change	18.9%	26.09%
Gross Profit	$30.82M	$32.09M
YoY Change	22.92%	15.38%
Gross Profit Margin	65.0%	64.02%
Selling, General & Admin	$17.41M	$17.94M
YoY Change	12.63%	15.19%
% of Gross Profit	56.5%	55.91%
Research & Development	$4.224M	$4.516M
YoY Change	22.01%	34.97%
% of Gross Profit	13.71%	14.07%
Depreciation & Amortization	$2.390M	$2.326M
YoY Change	2.66%	-4.83%
% of Gross Profit	7.76%	7.25%
Operating Expenses	$21.64M	$22.45M
YoY Change	14.35%	1.94%
Operating Profit	$9.180M	$9.632M
YoY Change	49.27%	66.53%
Interest Expense	$650.0K	$867.0K
YoY Change	-32600.0%
% of Operating Profit	7.08%	9.0%
Other Income/Expense, Net
YoY Change
Pretax Income	$9.826M	$10.32M
YoY Change	59.82%	85.99%
Income Tax	$2.324M	$2.221M
% Of Pretax Income	23.65%	21.52%
Net Earnings	$7.502M	$8.098M
YoY Change	37.5%	130.38%
Net Earnings / Revenue	15.82%	16.16%
Basic Earnings Per Share	$0.34	$0.36
Diluted Earnings Per Share	$0.33	$0.36
COMMON SHARES
Basic Shares Outstanding	22.26M	22.16M
Diluted Shares Outstanding	22.48M	22.45M

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$97.02M	$90.18M
YoY Change	21.67%	19.15%
Cash & Equivalents	$18.05M	$19.49M
Short-Term Investments	$78.97M	$70.69M
Other Short-Term Assets	$5.100M	$4.076M
YoY Change	-8.9%	0.17%
Inventory	$56.20M	$53.83M
Prepaid Expenses
Receivables	$23.88M	$26.41M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$182.2M	$174.5M
YoY Change	18.96%	17.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.36M	$37.02M
YoY Change	-31.41%	135.01%
Goodwill	$65.95M	$65.95M
YoY Change	0.0%	0.0%
Intangibles	$43.20M	$44.00M
YoY Change	-10.12%	-11.29%
Long-Term Investments
YoY Change
Other Assets	$3.152M	$5.012M
YoY Change	-16.21%	409.35%
Total Long-Term Assets	$151.8M	$152.0M
YoY Change	1.96%	0.69%
TOTAL ASSETS
Total Short-Term Assets	$182.2M	$174.5M
Total Long-Term Assets	$151.8M	$152.0M
Total Assets	$334.0M	$326.5M
YoY Change	10.58%	9.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.371M	$3.519M
YoY Change	53.48%	23.73%
Accrued Expenses	$21.79M	$21.69M
YoY Change	13.31%	27.49%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$29.03M	$25.86M
YoY Change	23.85%	10.47%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.145M	$16.71M
YoY Change	-87.6%	567.72%
Total Long-Term Liabilities	$2.145M	$16.71M
YoY Change	-87.6%	567.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$29.03M	$25.86M
Total Long-Term Liabilities	$2.145M	$16.71M
Total Liabilities	$45.38M	$42.64M
YoY Change	11.21%	3.02%
SHAREHOLDERS EQUITY
Retained Earnings	$110.1M	$105.7M
YoY Change	16.0%	14.65%
Common Stock	$198.5M	$197.2M
YoY Change	6.13%	6.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$288.6M	$283.8M
YoY Change
Total Liabilities & Shareholders Equity	$334.0M	$326.5M
YoY Change	10.58%	9.03%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	$7.502M	$8.098M
YoY Change	37.5%	130.38%
Depreciation, Depletion And Amortization	$2.390M	$2.326M
YoY Change	2.66%	-4.83%
Cash From Operating Activities	$11.83M	$11.90M
YoY Change	61.13%	28.71%
INVESTING ACTIVITIES
Capital Expenditures	$1.060M	$2.803M
YoY Change	-330.43%	-388.08%
Acquisitions
YoY Change
Other Investing Activities	-$8.800M	-$6.836M
YoY Change	10.0%
Cash From Investing Activities	-$9.850M	-$9.639M
YoY Change	16.43%	890.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.130M	502.0K
YoY Change	45.78%	-119.42%
NET CHANGE
Cash From Operating Activities	11.83M	11.90M
Cash From Investing Activities	-9.850M	-9.639M
Cash From Financing Activities	-3.130M	502.0K
Net Change In Cash	-1.150M	2.766M
YoY Change	-64.78%	-51.39%
FREE CASH FLOW
Cash From Operating Activities	$11.83M	$11.90M
Capital Expenditures	$1.060M	$2.803M
Free Cash Flow	$10.77M	$9.100M
YoY Change	38.04%	-10.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	7239000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	-0	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001158895
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	0
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	254151000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	6038000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1189000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	508000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	0
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1167000	usd
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	145000	usd
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2743000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	257787000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3515000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1820000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	164000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1136000	usd
CY2022Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	48000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-54000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	834000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1671000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	95000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-485000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-1954000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-1000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	919000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4239000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2610000	usd
	lmat	Increase Decrease In Inventory And Other Deferred Costs IncreaseDecreaseInInventoryAndOtherDeferredCosts	4272000	usd
	lmat	Increase Decrease In Inventory And Other Deferred Costs IncreaseDecreaseInInventoryAndOtherDeferredCosts	3536000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-922000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-403000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-987000	usd
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	141000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14182000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13959000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4933000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1509000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12603000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1509000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5073000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	672000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	181000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	149000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6215000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5488000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1323000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4965000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	98000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-552000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	354000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6933000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19488000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20788000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50115000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42108000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	97190000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	81669000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	580000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	612000	usd
	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	32000	usd
	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-0	usd
	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	-0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	580000	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	18174000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	14929000	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	3775000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3662000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	27151000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	26688000	usd
CY2023Q2	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	4731000	usd
CY2022Q4	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	4992000	usd
CY2023Q2	lmat	Inventory And Other Deferred Costs InventoryAndOtherDeferredCosts	53831000	usd
CY2022Q4	lmat	Inventory And Other Deferred Costs InventoryAndOtherDeferredCosts	50271000	usd
CY2023Q2	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	1800000	usd
CY2022Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	1500000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	3100000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	71394000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	27395000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	43999000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	70854000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24327000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	46527000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1509000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1596000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3068000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3112000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2980000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5772000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5440000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5041000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4764000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4378000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0525	pure
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	564000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	638000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1144000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1163000	usd
CY2023Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	158000	usd
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	161000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	320000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	324000	usd
CY2023Q2	us-gaap	Lease Cost LeaseCost	722000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	799000	usd
	us-gaap	Lease Cost LeaseCost	1464000	usd
	us-gaap	Lease Cost LeaseCost	1487000	usd
CY2023Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	729000	usd
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	810000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1466000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1484000	usd
CY2023Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	841000	usd
CY2022Q2	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2240000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1313000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2381000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y9M18D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y2M12D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0507	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0488	pure
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1651000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3231000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3060000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2556000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2431000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2398000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4601000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3121000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	16807000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9103000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10770000	usd
CY2023Q2	lmat	Accrued Purchases Current AccruedPurchasesCurrent	6277000	usd
CY2022Q4	lmat	Accrued Purchases Current AccruedPurchasesCurrent	3748000	usd
CY2023Q2	lmat	Accrued Expenses Current AccruedExpensesCurrent	3132000	usd
CY2022Q4	lmat	Accrued Expenses Current AccruedExpensesCurrent	4640000	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	421000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	449000	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	121000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	108000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	273000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	252000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19327000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19967000	usd
CY2023Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities	1486000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities	1354000	usd
CY2023Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	578000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	636000	usd
CY2023Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	200000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	177000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2264000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2167000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	97190000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	81669000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1312000	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1136000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2602000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2303000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1312000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1136000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2602000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2303000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1660
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	984
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	180000
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	43000
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	8098000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	3515000	usd
	us-gaap	Net Income Loss NetIncomeLoss	14138000	usd
	us-gaap	Net Income Loss NetIncomeLoss	9553000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22213000
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21958000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22162000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21947000
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.64
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	8098000	usd
	us-gaap	Net Income Loss NetIncomeLoss	9553000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21958000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22162000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21947000
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	238000
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	171000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	209000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	168000
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22451000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22129000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22371000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22115000
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	163000
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	328000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	290000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	390000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2783000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3991000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1339000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1492000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-40000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-27000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1379000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1519000	usd

Files In Submission

Name	View Source	Status
0001437749-23-022476-index-headers.html	Edgar Link	pending
0001437749-23-022476-index.html	Edgar Link	pending
0001437749-23-022476.txt	Edgar Link	pending
0001437749-23-022476-xbrl.zip	Edgar Link	pending
ex_551960.htm	Edgar Link	pending
ex_551961.htm	Edgar Link	pending
ex_551962.htm	Edgar Link	pending
ex_551963.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lmat-20230630.xsd	Edgar Link	pending
lmat20230630_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
lmat-20230630_def.xml	Edgar Link	unprocessable
lmat-20230630_lab.xml	Edgar Link	unprocessable
lmat-20230630_pre.xml	Edgar Link	unprocessable
lmat20230630_10q_htm.xml	Edgar Link	completed
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
lmat-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LMAT
LEMAITRE VASCULAR INC Stock $lmat

2023 Q3 Form 10-Q Financial Statement

#000143774923022476 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LMAT LEMAITRE VASCULAR INC Stock $lmat

2023 Q3 Form 10-Q Financial Statement

#000143774923022476 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LMAT
LEMAITRE VASCULAR INC Stock $lmat